-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Pfizer, Lowers Price Target to $28

Benzinga·07/08/2026 14:58:00
Listen to the news
JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $30 to $28.